NPI: 1750788238 · RAEFORD, NC 28376 · General Acute Care Hospital · NPI assigned 11/26/2014
Authorized official FISER, JOSEPH controls 20+ related entities in our dataset. Read more
| Authorized Official | FISER, JOSEPH (VP CORP REVENUE CYCLE/MANAGED CARE) |
| Parent Organization | CUMBERLAND COUNTY HOSPITAL SYSTEM INC |
| NPI Enumeration Date | 11/26/2014 |
Other providers sharing the same authorized official: FISER, JOSEPH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 46,605 | $1.95M |
| 2019 | 70,685 | $2.27M |
| 2020 | 62,391 | $1.42M |
| 2021 | 84,015 | $3.33M |
| 2022 | 96,599 | $5.28M |
| 2023 | 100,528 | $4.97M |
| 2024 | 109,020 | $5.60M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 46,746 | 41,379 | $7.48M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 46,528 | 41,857 | $3.94M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 14,205 | 12,278 | $3.13M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 16,683 | 14,856 | $2.52M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,472 | 1,228 | $1.09M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 17,594 | 14,932 | $1.04M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 850 | 719 | $541K |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,498 | 9,514 | $415K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 15,619 | 10,842 | $381K |
| 71046 | Radiologic examination, chest; 2 views | 8,583 | 7,438 | $346K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,154 | 3,479 | $332K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 13,596 | 11,526 | $322K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,220 | 4,439 | $275K |
| 80053 | Comprehensive metabolic panel | 32,858 | 27,631 | $274K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,252 | 1,033 | $267K |
| 85027 | 30,768 | 25,488 | $186K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 10,918 | 10,271 | $173K |
| 71045 | Radiologic examination, chest; single view | 5,308 | 4,531 | $161K |
| 81025 | 19,250 | 17,073 | $145K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,305 | 3,788 | $144K |
| J3490 | Unclassified drugs | 43,109 | 24,856 | $135K |
| 87400 | 8,076 | 5,564 | $111K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,248 | 979 | $97K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 377 | 283 | $93K |
| 36415 | Collection of venous blood by venipuncture | 43,696 | 34,611 | $92K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11,834 | 10,074 | $88K |
| 84484 | 11,048 | 7,131 | $87K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,232 | 1,111 | $74K |
| 81001 | 22,508 | 19,459 | $73K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,567 | 2,300 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,566 | 2,299 | $67K |
| 83690 | 9,866 | 8,496 | $66K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,361 | 7,622 | $66K |
| G0378 | Hospital observation service, per hour | 283 | 135 | $64K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,422 | 12,073 | $53K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 593 | 516 | $46K |
| 76801 | 169 | 156 | $29K | |
| A9270 | Non-covered item or service | 24,119 | 10,881 | $24K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,545 | 6,328 | $21K |
| 81003 | 8,218 | 7,176 | $18K | |
| 84702 | 1,610 | 1,423 | $17K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,671 | 6,037 | $17K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,243 | 1,906 | $16K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 330 | 274 | $16K |
| 87070 | 1,364 | 1,241 | $14K | |
| 96376 | 204 | 128 | $12K | |
| 85730 | 2,534 | 2,038 | $12K | |
| 87420 | 858 | 827 | $12K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,748 | 2,235 | $11K |
| 87088 | 1,389 | 1,213 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 367 | 347 | $9K |
| 83735 | 1,411 | 1,129 | $8K | |
| 87210 | 2,070 | 1,835 | $8K | |
| 85610 | 2,652 | 2,154 | $8K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,269 | 1,720 | $8K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 55 | 54 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,109 | 926 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 550 | 430 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 192 | 178 | $5K |
| 82553 | 702 | 562 | $5K | |
| 82550 | 1,149 | 945 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 236 | 212 | $5K |
| 73562 | 39 | 37 | $4K | |
| 83605 | 365 | 251 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 111 | 103 | $3K |
| 0012A | 58 | 58 | $3K | |
| 87040 | 329 | 187 | $3K | |
| 80061 | Lipid panel | 196 | 192 | $3K |
| 0353U | 223 | 173 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 303 | 228 | $3K |
| 0001A | 35 | 35 | $2K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 13 | 12 | $2K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 153 | 121 | $2K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 96 | 89 | $2K |
| 82947 | 679 | 425 | $2K | |
| 0011A | 43 | 42 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 30 | 27 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 107 | 93 | $2K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 358 | 229 | $1K |
| 73630 | 13 | 12 | $1K | |
| 73610 | 14 | 12 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 162 | 133 | $918.60 |
| 82652 | 25 | 25 | $871.89 | |
| 86592 | 194 | 183 | $842.92 | |
| 87077 | 145 | 124 | $835.93 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 19 | 13 | $723.12 |
| 83880 | 15 | 14 | $486.59 | |
| 83021 | 25 | 24 | $483.80 | |
| 82077 | 311 | 208 | $459.15 | |
| 87340 | 42 | 42 | $446.80 | |
| J1630 | Injection, haloperidol, up to 5 mg | 80 | 64 | $419.39 |
| 86900 | 112 | 90 | $415.55 | |
| 86901 | 112 | 90 | $415.55 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 13 | $387.30 |
| 86140 | 90 | 69 | $384.00 | |
| 82150 | 55 | 44 | $383.60 | |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 28 | 13 | $363.62 |
| 81002 | 45 | 36 | $295.99 | |
| 94760 | 19 | 13 | $293.34 | |
| 85379 | 57 | 37 | $286.78 | |
| 80143 | 120 | 66 | $236.51 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 50 | 37 | $182.28 |
| 86787 | 12 | 12 | $176.55 | |
| J7510 | Prednisolone oral, per 5 mg | 74 | 72 | $176.50 |
| 82248 | 30 | 25 | $143.75 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 13 | 13 | $123.06 |
| 86850 | 12 | 12 | $110.00 | |
| 80179 | 118 | 64 | $104.39 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 27 | 25 | $96.81 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 30 | 26 | $88.73 |
| 87186 | 14 | 12 | $86.16 | |
| C9113 | Injection, pantoprazole sodium, per vial | 17 | 13 | $78.69 |
| J2704 | Injection, propofol, 10 mg | 16 | 12 | $64.90 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 76 | 65 | $45.63 |
| 81005 | 16 | 13 | $27.75 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 546 | 414 | $0.00 |